Berg taps into supercomputer to battle COVID-19 variants

The advanced biotech analysis company is harnessing the power of a formidable supercomputer to discover potential treatments for the virus and mutations.
Several COVID-19 vaccines have been approved and administered to millions of people around the globe. Since the virus’s arrival, researchers also have been on the hunt for drugs that can effectively battle the disease in patients that receive a positive diagnosis.
Berg, a company that uses proprietary artificial intelligence (AI) tech to identify and pursue potential drug candidates, recently used its proprietary AI model to pinpoint drugs that could be repurposed to combat the numerous COVID-19 variants that have popped up around the world.

Related Keywords

South Africa ,United States ,United Kingdom ,Brazil ,American ,Niven Narain ,Pfizer ,Astrazeneca ,Oak Ridge National Laboratory ,Oak Ridge ,Covid 19 ,Preclinical Research ,Clinical Evolution ,Data Management ,Preclinical ,Corona Virus ,Artificial Intelligence ,ஒன்றுபட்டது மாநிலங்களில் ,ஒன்றுபட்டது கிஂக்டம் ,பிரேசில் ,அமெரிக்கன் ,நிவேன் நரேன் ,ஃபைசர் ,ஓக் ரிட்ஜ் தேசிய ஆய்வகம் ,ஓக் ரிட்ஜ் ,மருத்துவ பரிணாமம் ,தகவல்கள் மேலாண்மை ,கொரோனா வைரஸ் ,செயற்கை உளவுத்துறை ,